MedOncMD

To provide the information your oncologist is not telling you or doesn't have the time to!

  • Home
  • Blog
    • The essentials
    • Art of Oncology
    • Prevention and Healthy Lifestyle
    • Research Advances
    • Navigation Corner
    • Video Library
  • Meet and Greet
    • About Dr Thomas
    • About Dr Landau
  • Ask MedOncMD?
  • đź§  How I Create My Blog Posts

Research Advances

Stay Informed About the Latest Oncology Breakthroughs

Explore the forefront of oncological research with our “Research Advances” category. Discover cutting-edge studies, innovative treatments, and scientific insights into cancer. Stay up-to-date with the latest breakthroughs and advancements in the field of oncology to make informed decisions about your health or that of your loved ones. Dive into the world of scientific progress and gain a deeper understanding of how research is shaping the future of cancer care.

Adjuvant Pembrolizumab in Resected Merkel Cell Carcinoma: One Step Forward in the STAMP Trial

A firewall against relapse — adjuvant immunotherapy steps into the spotlight for resected Merkel cell carcinoma.

Ocular-Sparing Therapy in Uveal Melanoma: A New Era Emerges with Darovasertib

Protecting vision, preserving the person — the promise of ocular-sparing oncology.

When “Small Things” Aren’t Small: From Antibiotics to PDL1 to Chronobiology in Immunotherapy

Details once dismissed as trivial—like timing—can quietly reshape cancer care.

Dual Checkpoint Therapy vs. PD-1 Monotherapy in MSI-H Colorectal Cancer: Do We Really Need to Give Everyone Ipi/Nivo?

Sometimes restraint is the wiser choice — half of patients are cured with PD-1 alone.

A New Chapter in Melanoma Care? Encouraging Phase 3 Results for Cylembio® + Pembrolizumab

When innovation meets immune activation, new possibilities emerge for melanoma care.

TCR Therapy Targets PRAME in Melanoma: Early Results from IMA203 Show Real Promise Presented From ASCO 2025

Targeting PRAME with TCR-T cell therapy may mark a new era for immunotherapy in melanoma and beyond.

Exercise After Cancer: A Billion-Dollar Drug We Already Have (But Often Don’t Take)

The CHALLENGE trial proves what we’ve long suspected: structured exercise isn’t just good for you—it can save your life.

When Immune Therapy Works in Resectable Cancers: To Resect or To Not Resect.

When immune therapy clears cancer, the real question for resectable tumors becomes: Do we still need to resect?

Melanoma Highlights from ASCO: Targeted Therapy, Immunotherapy, and Innovations

From early-stage to brain metastases, ASCO’s latest melanoma abstracts spotlight the growing power of targeted and immune-based therapies across disease stages.

Our New Compass in the Fog of Cancer Care: Updates from ASCO 2025

ctDNA is helping us track what truly matters—real-time, personalized signals that guide smarter decisions in cancer care.

  • Page 1
  • Page 2
  • Page 3
  • …
  • Page 12
  • Next

Recent Posts

  • The mRNA moment in melanoma: a 5-year update—and a flashback to the COVID era
  • Emerging Data in Intratumoral Immunotherapy: Replimmune’s RP1 + Nivolumab in Non‑Melanoma Skin Cancers and Acral Melanoma
  • 12 Things I Learned in My First 6 Weeks at AdventHealth
  • 2025 Reflections and 2026 Aspirations: A Medical Oncologist’s Journey in Clinical Excellence, Innovation, and Intentional Living
  • What I’m Most Thankful For This Thanksgiving Weekend

Categories

  • Art of Oncology (97)
  • Current News (16)
  • Immunotherapy News (12)
  • Navigation Corner (6)
  • Prevention and Healthy Lifestyle (18)
  • Reflections (3)
  • Research Advances (120)
    • Clinical Trials (51)
    • Immunotherapy (33)
    • New Treatments and Therapies (44)
  • The essentials (41)
    • Radiology (4)
  • Travel Health (1)
  • Uncategorized (10)
  • Varied Cancer Perspectives (126)
    • Biliary tract cancer (3)
    • Bladder Cancer (3)
    • Breast Cancer (10)
    • Cervical Cancer (2)
    • CNS Cancers (1)
    • Colorectal cancer (15)
    • Esophageal Cancer (2)
    • Gastric cancer (6)
    • Hepatic Tumors (1)
    • Leiomyosarcoma (2)
    • Leukemia (3)
    • Lung Cancer (11)
    • Lymphoma (3)
    • Melanoma (34)
    • Multiple Myeloma (3)
    • Neuroendocrine cancer (2)
    • Ovarian Cancer (3)
    • Pancreatic Cancer (5)
    • Prostate Cancer (5)
    • Sarcoma (2)
    • Sickle Cell Disease (4)
    • Skin Cancer (9)
    • Thyroid cancer (1)
    • Urothelial Cancer (1)
  • Video (2)
  • Weekly Newsletter (6)

Get in touch!

  • Facebook
  • Instagram
  • TikTok
  • LinkedIn


Meet the authors

Dr. Sajeve Thomas
Dr Daniel Landau


Subscribe


  • Home
  • Blog
    • The essentials
    • Art of Oncology
    • Prevention and Healthy Lifestyle
    • Research Advances
    • Navigation Corner
    • Video Library
  • Meet and Greet
    • About Dr Thomas
    • About Dr Landau
  • Ask MedOncMD?
  • đź§  How I Create My Blog Posts
© 2026 MedOncMD. Minimal Theme by SPYR
✕
  • Home
  • Blog
    • The essentials
    • Art of Oncology
    • Prevention and Healthy Lifestyle
    • Research Advances
    • Navigation Corner
    • Video Library
  • Meet and Greet
    • About Dr Thomas
    • About Dr Landau
  • Ask MedOncMD?
  • đź§  How I Create My Blog Posts